Bactiguard products

Our infection prevention
solutions reduce the risk of
healthcare associated infections,
increase patient safety and
reduce the use of antibiotics.

Bactiguard products

Bactiguard's interim report Q3

Bactiguard Holding AB (publ) published the interim report for the third quarter on Thursday November 5, 2020 at 08:00 CET.

In connection with this, a audiocast for investors, analysts and media was held at 11:00 CET on November 5, where CEO Cecilia Edström and CFO Gabriella Björknert presented the interim report and answered questions.

Presentation (PDF)

Hydrocyn® aqua Advanced disinfectant
- proven effective against the new Coronavirus

Hydrocyn® aqua is a non-alcoholic disinfectant solution for, for example, skin and surfaces. The active substance hypochlorous acid (HOCl) is a part of the human immune system. Hydrocyn® aqua kills:

  • Bacteria
  • Fungi
  • Virus

Hydrocyn® aqua is proven effective against the SARS-CoV-2 virus that causes COVID-19 and against previous strains of coronavirus.

Our products prevent healthcare associated infections

The Bactiguard technology reduces microbial adhesion to the surface of medical devices, which decreases the risk of biofilm formation leading to infection.

Combines surveillance and infection prevention

The BIP Foley TempSensor is an indwelling urinary catheter which combines continuous temperature monitoring with Bactiguard’s infection prevention technology.

Proven effective against the new corona virus

Hydrocyn® aqua is a non-alcoholic disinfectant solution for, for example, skin and surfaces, proven effective against the new coronavirus SARS-CoV-2.

Interim report Q3 (January - September) 2020

Bactiguard Holding AB (publ) published the interim report for the third quarter on Thursday November 5, 2020 at 08:00 CET.